Source: Health Products and Food Branch (CA) Revision Year: 2022
ASA – Acetylsalicylic Acid Delayed Release Tablets USP.
| Route of Administration | Dosage Form / Strength | Clinically Relevant Nonmedicinal Ingredients |
|---|---|---|
| Oral | Acetylsalicylic Acid Delayed-Release Tablets, USP, 81mg | Lactose |
For a complete listing see DOSAGE FORMS, COMPOSITION AND PACKAGING.
Each round, blue, coated tablet contains 81 mg Acetylsalicylic Acid with the non-medicinal ingredients: Colloidal Silicon Dioxide, FD&C Blue No. 1 Aluminum Lake, Hydroxypropyl Methylcellulose, Lactose Anhydrous, Methacrylic Acid Copolymer, Methylated Silica, Methylcellulose, Polydimethylsiloxane, Polyethylene Glycol, Pregelatinized Starch, Sodium Bicarbonate, Sodium Lauryl Sulphate, Sorbitan Tristearate, Stearic Acid, Talc, Titanium Dioxide and Triethyl Citrate.
Supplied in bottles of 30, 120, 150, 180, 225, 255, 300, 360, 365, 500 and 1000 (for dispensing use only) tablets.
| Marketing Informations | Authorization Dates |
|---|---|
|
Authorization holder:
Pharmascience Inc., 6111 Royalmount Ave., Suite 100, Montréal, Québec, H4P 2T4 263622 |
Date of revision:
May 30, 2022 |
| Drug | Countries | |
|---|---|---|
| ASA | Canada, Ecuador, Finland, Mexico |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
